Contracts Finder · Award
NHS National Generic Pharmaceuticals Interim 2
A public procurement published by NHS England via Contracts Finder.
- £12.3m
- Award value
- £18.8m
- Tender value
- 51
- Suppliers
- 51
- Awards
- 1
- Notices
- Award
- Stage
Overview
NHS National Generic Pharmaceuticals Interim 2 2020 Offer reference number: CM/PHG/20/5619 Period of framework agreement: 12 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 36 months. The total maximum duration of the framework agreement to be no more than 48 months Potential periods of call-offs under the framework agreement: Hospital only products - All regions: 01/02/2021 to 31/01/2022 Orals (plus non-parenterals) - All regions: 01/03/2021 to 28/02/2022
Key details
- Buyer
- NHS England
- Source
- Contracts Finder
- Lifecycle stage
- Award
- Status
- complete
- CPV classification
- 33690000 — Various medicinal products
- Currency
- GBP
- Total award value
- £12,327,097
- Tender value
- £18,767,757
- First published
- 16 Feb 2021
- Last updated
- 16 Feb 2021
Awards
51 awards recorded on this procurement.
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
- Abbvie LtdCompanies House 08004972
- Accord-UK LtdCompanies House 00079585
- Altan Pharma Ltd
- Amarox LimitedCompanies House 10997632
- Aspire Pharma LimitedCompanies House 06828501
- Aventis Pharma ltd t/a Sanofi
- Baxter Healthcare LtdCompanies House 00461365
- Bristol Laboratories LimitedCompanies House 03393503
- Brown & Burk UK LtdCompanies House 04082256
- Cipla (EU) LtdCompanies House 04513292
- Consilient Health Ltd
- Crescent Pharma LtdCompanies House 04750933
- CST Pharma Limited
- Drugsrus LtdCompanies House 04916914
- Essential-Healthcare LtdCompanies House 09146129
- Focus Pharmaceuticals LtdCompanies House 04522142
- Fresenius Kabi LimitedCompanies House 02182135
- GlaxoSmithKline UK LimitedCompanies House 04310159
- Glenmark Pharmaceuticals Europe LimitedCompanies House 05040260
- Healthcare Pharma LtdCompanies House 03870326
- HFA Healthcare Products Limited
- Kent Pharma Ltd
- Laboratorio Reig Jofre SA
- Lexon UK LtdCompanies House 03076698
- Macleods Pharma UK LimitedCompanies House 06455382
- Manx Healthcare LtdCompanies House 02904497
- Martindale Pharma
- medac Pharma LLPCompanies House OC415849
- Medley Pharma LtdCompanies House 09196622
- Medreich PLCCompanies House 03122988
- Mercury Pharmaceuticals LimitedCompanies House 02619880
- Milpharm Ltd/aurobinbdo
- Morningside Pharmaeuticals
- MylanCompanies House 16560988
- Necessity Supplies LimitedCompanies House 02010112
- Panpharma UK LimitedCompanies House 09519853
- Pfizer LtdCompanies House 00526209
- QDEM PHARMACEUTICALS LIMITEDCompanies House 07841452
- Ranbaxy UK
- Rivopharm UK LtdCompanies House 05986035
- Sandoz LtdCompanies House 01547204
- Sciecure Pharma LimitedCompanies House 08635872
- Selective Supplies Ltd.Companies House 03794482
- Syri Limited (T/A Thame Laboratories)
- Teva UK LimitedCompanies House 00302461
- Thornton and Ross LtdCompanies House 00185947
- Tillomed Laboratories ltdCompanies House 02544103
- UpJohn Limited UKCompanies House 11678221
- Waymade PLCCompanies House 01856320
- Wockhardt UK LimitedCompanies House 05835570
- Zentiva Pharma UK LtdCompanies House 02158996
Frameworks & programmes
More from NHS England
FAQs about this procurement
Who is the buyer for "NHS National Generic Pharmaceuticals Interim 2"?
NHS National Generic Pharmaceuticals Interim 2 is a UK public-sector procurement published by NHS England via Contracts Finder.
Has "NHS National Generic Pharmaceuticals Interim 2" been awarded?
Yes — 51 awards are recorded, with a reported total value of £12,327,097. The current lifecycle stage is "Award".
Which suppliers are involved in "NHS National Generic Pharmaceuticals Interim 2"?
51 suppliers are linked: Abbvie Ltd, Accord-UK Ltd, Altan Pharma Ltd, Amarox Limited, Aspire Pharma Limited, Aventis Pharma ltd t/a Sanofi, Baxter Healthcare Ltd, Bristol Laboratories Limited.
What is "NHS National Generic Pharmaceuticals Interim 2" worth?
The reported award value is £12,327,097.
When was "NHS National Generic Pharmaceuticals Interim 2" published?
It was first published on 16 Feb 2021 and last updated on 16 Feb 2021, across 1 notice.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable